Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension

NCT00237783 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Unable to recruit enough subjects

Conditions

Hemodialysis
Hypotension

Interventions

DRUG: dialysate sodium (140 mmol/L)
DRUG: individualized dialysate sodium

Sponsor

Yale University